Avitia

Montréal, Canada

Avitia improves cancer treatment via advanced molecular testing solutions, offers testing tools for use onsite, bioinformatics driven by AI.

$5.0M raised

Feb 2025

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Avitia raised?

Avitia has raised $5.0M in total funding. The most recent round was Seed. The last funding was announced in February 2025.

Who are Avitia's investors?

Avitia's investors include PacBridge Capital Partners.

Where is Avitia headquartered?

Avitia is headquartered in Montréal, Canada.

What does Avitia do?

Avitia improves cancer treatment via advanced molecular testing solutions, offers testing tools for use onsite, bioinformatics driven by AI.

What stage is Avitia at?

Avitia is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 27, 2025.

MLA

"Avitia — Funding & Investors." VCBacked, February 27, 2025, https://www.vcbacked.co/company/avitia. Accessed July 2, 2026.

APA

VCBacked. (2025). Avitia — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/avitia

Wikipedia (cite web)

{{cite web |title=Avitia — Funding & Investors |url=https://www.vcbacked.co/company/avitia |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 27, 2025.